当前位置：
X-MOL 学术
›
J. Diabetes its Complicat.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?
Journal of Diabetes and its Complications ( IF 3 ) Pub Date : 2023-11-07 , DOI: 10.1016/j.jdiacomp.2023.108647 Emir Muzurović 1 , Volkan Demirhan Yumuk 2 , Manfredi Rizzo 3
Journal of Diabetes and its Complications ( IF 3 ) Pub Date : 2023-11-07 , DOI: 10.1016/j.jdiacomp.2023.108647 Emir Muzurović 1 , Volkan Demirhan Yumuk 2 , Manfredi Rizzo 3
Affiliation
Abstract not available
中文翻译：
GLP-1 和双重 GIP/GLP-1 受体激动剂在超重/肥胖患者中预防动脉粥样硬化性心血管疾病：我们现在进展如何？
摘要不可用
更新日期：2023-11-12
中文翻译：
GLP-1 和双重 GIP/GLP-1 受体激动剂在超重/肥胖患者中预防动脉粥样硬化性心血管疾病：我们现在进展如何？
摘要不可用
京公网安备 11010802027423号